› added 7 years ago
170
TIL a study involving 165 patients with Alzheimer’s found that those treated with the highest dose of an antibody drug, aducanumab, experienced an almost complete clearance of amyloid plaques (that supposedly lead to the irreversible memory loss and cognitive decline).